Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M40.8Revenue (TTM) $M0.7Net Margin (%)-3,799.2Altman Z-Score-14.2
Enterprise Value $M19.5EPS (TTM) $9.3Operating Margin %-4,499.0Piotroski F-Score4
P/E(ttm)0.4Beneish M-Score-2.5Pre-tax Margin (%)-3,802.9Higher ROA y-yY
Price/Book10.810-y EBITDA Growth Rate %-12.1Quick Ratio4.0Cash flow > EarningsN
Price/Sales38.25-y EBITDA Growth Rate %-34.9Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-62.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-211.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSFirst Eagle Investment 2010-03-31 Sold Out $474 - $558.06
($499.42)
$ 3.50-99%Sold Out0
AEZSFirst Eagle Investment 2009-12-31 Reduce-0.02%$473.4 - $750
($607.39)
$ 3.50-99%Reduce -91.09%208
AEZSFirst Eagle Investment 2009-09-30 Buy 0.02%$534 - $1698
($960.59)
$ 3.50-100%New holding2,330
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy600$60-94.17view
Ernst, JrgenDirector 2014-11-12Buy394$61.79-94.34view
Ernst, JrgenDirector 2014-11-12Buy76$61.49-94.31view
Ernst, JrgenDirector 2014-11-12Buy31$61.4-94.3view
Ernst, JrgenDirector 2014-11-12Buy149$61.46-94.31view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy85$56.5-93.81view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy10$56.97-93.86view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy344$57-93.86view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy30$57.5-93.91view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy1,281$58-93.97view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016 Nov 15 2016
    Aeterna Zentaris 3Q Loss $6M or 61c/Share (AEZS) Nov 09 2016
    AEterna Zentaris Inc. (USA) (AEZS) Lines Up A Binary Event Reversal For The First Quarter Nov 09 2016
    Aeterna Zentaris reports 3Q loss Nov 08 2016
    Aeterna Zentaris reports 3Q loss Nov 08 2016
    11.08.2016 Aeterna Zentaris Reports Third Quarter 2016 Financial and Operating Results Nov 08 2016
    Aeterna Zentaris Reports Third Quarter 2016 Financial and Operating Results Nov 08 2016
    11.01.2016 Aeterna Zentaris Announces Closing of US$7,560,000 Registered Direct Offering of Common... Nov 01 2016
    Aeterna Zentaris Announces Closing of US$7,560,000 Registered Direct Offering of Common Shares and... Nov 01 2016
    Here Are Three Big Biotech Movers And Our Take On What’s Next Oct 28 2016
    10.28.2016 Aeterna Zentaris to Announce Third Quarter 2016 Financial and Operating Results on... Oct 28 2016
    Aeterna Zentaris to Announce Third Quarter 2016 Financial and Operating Results on November 8, 2016 Oct 28 2016
    10.27.2016 Aeterna Zentaris Announces US$7,560,000 Registered Direct Offering of Common Shares and... Oct 27 2016
    Aeterna Zentaris Announces US$7,560,000 Registered Direct Offering of Common Shares and Warrants Oct 27 2016
    10.26.2016 Aeterna Zentaris Completes Patient Recruitment for Confirmatory Phase 3 Trial of... Oct 26 2016
    Aeterna Zentaris Completes Patient Recruitment for Confirmatory Phase 3 Trial of Macrilen™ Oct 26 2016
    Aeterna Zentaris (AEZS) Jumps: Stock Adds 5.2% in Session Oct 21 2016
    Aeterna Signs Marketing Deal With STA (AEZS) Oct 13 2016
    10.12.2016 Aeterna Zentaris and Specialised Therapeutics Asia Sign Exclusive License Agreement for... Oct 12 2016
    Aeterna Zentaris and Specialised Therapeutics Asia Sign Exclusive License Agreement for the... Oct 12 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)